Acumen Pharmaceuticals, Inc. Total Liabilities and Equity
Acumen Pharmaceuticals, Inc. (ABOS) had Total Liabilities and Equity of $116.01 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-12
- 2026-06-30: Liabilities and Equity $116.01M.
- 2026-03-31: Liabilities and Equity $133.63M.
- 2025-12-31: Liabilities and Equity $122.83M.
- 2025-09-30: Liabilities and Equity $142.22M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $116.01M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $133.63M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $122.83M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $142.22M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $171.90M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $204.48M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $238.99M 10-K · filed 2026-03-26 |
| 2024-09-30 | $266.98M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $288.91M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $300.97M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $310.13M 10-K · filed 2025-03-27 |
| 2023-09-30 | $286.37M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $177.41M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $187.86M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $196.59M 10-K · filed 2024-03-26 |
| 2022-09-30 | $203.26M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $211.68M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $220.09M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $230.33M 10-K · filed 2023-03-27 |
| 2021-09-30 | $234.85M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $72.94M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $44.43M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |